Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease

Sickle cell disease (SCD) is a chronic hemolytic anemia affecting millions worldwide with acute and chronic clinical manifestations and early mortality. While hydroxyurea (HU) and other treatment strategies managed to ameliorate disease severity, high inter-individual variability in clinical respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Akancha, Estepp, Jeremie H., Raja, Rubesh, Kang, Guolian, Ramkrishna, Doraiswami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144420/
https://www.ncbi.nlm.nih.gov/pubmed/35631651
http://dx.doi.org/10.3390/pharmaceutics14051065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144420/
https://www.ncbi.nlm.nih.gov/pubmed/35631651
http://dx.doi.org/10.3390/pharmaceutics14051065

Ejemplares similares